NASDAQ: BNTX · Life Sciences · 8 alerts · CIK 1776985
Share price
$85.26Close, Nov 16
Market cap
$21.4B
Shares outstanding
251.2MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BioNTech SE filings on SEC EDGAR ↗
Ugur Sahin, CEO, sold 63,209 shares of BioNTech SE at $92.31 to $95.37 a share (average $94.07) in 2 transactions, worth $5.95M in total between Oct 8, 2026 and Oct 9, 2026. Shares held after the trade: 0 (-100.0%).
Ugur Sahin, CEO, sold 24,000 shares of BioNTech SE at $95.86 a share, worth $2.3M in total on Oct 7, 2026. Shares held after the trade: 63,209 (-27.5%).
Ugur Sahin, CEO, sold 93,000 shares of BioNTech SE at $96.81 to $97.23 a share (average $97.14) in 2 transactions, worth $9.03M in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 87,209 (-19.4%).
Ugur Sahin, CEO, sold 34,000 shares of BioNTech SE at $96.72 to $97.46 a share (average $97.09) in 2 transactions, worth $3.3M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 180,209 (-8.6%).
Ugur Sahin, CEO, sold 66,000 shares of BioNTech SE at $98.12 to $98.26 a share (average $98.19) in 2 transactions, worth $6.48M in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 214,209 (-13.0%).
Ugur Sahin, CEO, sold 64,000 shares of BioNTech SE at $96.22 to $98.60 a share (average $97.49) in 2 transactions, worth $6.24M in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 489,209 (-5.8%).